EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.1.1.128 | S-adenosyl-L-homocysteine + (S)-reticuline |
- |
Coptis japonica |
S-adenosyl-L-methionine + 3'-hydroxy-N-methyl-(S)-coclaurine |
- |
? |
2.1.1.128 | S-Adenosyl-L-methionine + (R)-norlaudanosoline |
- |
Coptis japonica |
S-Adenosyl-L-homocysteine + 6-O-methylnorlaudanosoline + 7-O-methylnorlaudanosoline |
- |
? |
2.1.1.128 | S-Adenosyl-L-methionine + (R)-norlaudanosoline |
92% of the activity with (S)-norlaudanosoline |
Argemone platyceras |
S-Adenosyl-L-homocysteine + 6-O-methylnorlaudanosoline + 7-O-methylnorlaudanosoline |
6-O-methylnorlaudanosoline + 7-O-methylnorlaudanosoline in the ratio 8:2 |
? |
2.1.1.128 | S-Adenosyl-L-methionine + (R,S)-2,3-dihydroxy-9,10-dimethoxytetrahydroprotoberberine |
5% of the activity with (S)-norlaudanosoline |
Argemone platyceras |
S-Adenosyl-L-homocysteine + ? |
- |
? |
2.1.1.128 | S-Adenosyl-L-methionine + (R,S)-4'-O-methylnorlaudanosoline |
34% of the activity with (S)-norlaudanosoline |
Argemone platyceras |
S-Adenosyl-L-homocysteine + norprotosinomenine |
- |
? |
2.1.1.128 | S-Adenosyl-L-methionine + (R,S)-5'-O-methylnorlaudanosoline |
81% of the activity with (S)-norlaudanosoline |
Argemone platyceras |
S-Adenosyl-L-homocysteine + 6-O-methyllaudanosoline |
- |
? |
2.1.1.128 | S-adenosyl-L-methionine + (R,S)-norlaudanosoline |
- |
Coptis japonica |
S-adenosyl-L-homocysteine + 6-O-methylnorlaudanosoline + 7-O-methylnorlaudanosoline |
- |
? |
2.1.1.128 | S-adenosyl-L-methionine + (R,S)-norlaudanosoline |
- |
Argemone platyceras |
S-adenosyl-L-homocysteine + 6-O-methylnorlaudanosoline + 7-O-methylnorlaudanosoline |
- |
? |
2.1.1.128 | S-adenosyl-L-methionine + (R,S)-norlaudanosoline |
- |
Thalictrum flavum subsp. glaucum |
S-adenosyl-L-homocysteine + (RS)-6-O-methylnorlaudanosoline |
- |
? |
2.1.1.128 | S-adenosyl-L-methionine + (RS)-norcoclaurine |
- |
Papaver somniferum |
S-adenosyl-L-homocysteine + (RS)-coclaurine |
- |
? |